Visual Abstract | DAPA-HF - American College of Cardiology
Efficacy results of randomized clinical trials with dapagliflozin... | Download Table
Forxiga (dapagliflozin) for Treatment of Type 2 Diabetes - Clinical Trials Arena
Ongoing Clinical Trials Assessing Dapagliflozin in Patients with Heart... | Download Scientific Diagram
Dapagliflozin in Real World - ppt download
New DECLARE-TIMI 58 Data Shine a Light on Diabetes Patients Most Likely to Benefit From Dapagliflozin | tctmd.com
Dapagliflozin helps reduce HbA1c and body weight in patients with type 2 diabetes as part of triple combination therapy: a subanalysis of four clinical studies - Virtual Meeting | EASD
Dapagliflozin for Heart Failure with Preserved Ejection Fraction: Will the DELIVER Study Deliver? | SpringerLink
Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials - The Lancet Diabetes & Endocrinology
Off the Beaten Path: Non-Insulin Medications to Manage Type 1 Diabetes - ppt download
Effect of Dapagliflozin in Patients With HFrEF Treated With Sacubitril/Valsartan: The DAPA-HF Trial - ScienceDirect
Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial - The Lancet Diabetes & Endocrinology
SGLT2 inhibitors – looking beyond glucose-lowering in diabetes | Cochrane UK
Efficacy and Safety of Dapagliflozin in Patients With CKD Across Major Geographic Regions - ScienceDirect
View of Dapagliflozin: Clinical practice compared with pre-registration trial data | British Journal of Diabetes
A pre-specified analysis of the DAPA-CKD trial demonstrates the effects of dapagliflozin on major adverse kidney events in patients with IgA nephropathy - Kidney International
Dapagliflozin in Heart Failure | NEJM Resident 360 <meta property="twitter:image" content="https://resident360files.nejm.org/image/upload/c_fit,f_auto,h_120,w_120/v1538599218/u8buf4o8mgdxgmfcczjk.png" /> <meta property="og:image" content="https ...
Figure 1 from Efficacy and safety of Dapagliflozin vs. Canagliflozin in addition to metformin for treatment of type 2 diabetes, a randomized, double-blind, non-inferiority clinical trial | Semantic Scholar
Practical Guide to Prescribing Sodium-Glucose Cotransporter 2 Inhibitors for Cardiologists - ScienceDirect
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction | NEJM
Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet Diabetes & Endocrinology
Efficacy data summary from the main phase 3 clinical trials of... | Download Table
